BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6187921)

  • 1. Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7.
    Grzonka Z; Lammek B; Kasprzykowski F; Gazis D; Schwartz IL
    J Med Chem; 1983 Apr; 26(4):555-9. PubMed ID: 6187921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8.
    Grzonka Z; Kasprzykowski F; Kojro E; Darlak K; Melin P; Fahrenholz F; Crause P; Boer R
    J Med Chem; 1986 Jan; 29(1):96-9. PubMed ID: 2416923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sarcosine or N-methylalanine in position 7 on the antagonistic properties of [1-deaminopenicillamine]- and [1-(beta-mercapto-beta, beta-cyclopentylmethylene-propionic acid)]-vasopressin.
    Gazis D; Schwartz IL; Lammek B; Grzonka Z
    Int J Pept Protein Res; 1984 Jan; 23(1):78-83. PubMed ID: 6199318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced selectivity of oxytocin antagonists containing sarcosine in position 7.
    Pavo I; Slaninova J; Klein U; Fahrenholz F
    J Med Chem; 1994 Jan; 37(2):255-9. PubMed ID: 7507528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activities of arginine-vasopressin analogues with 4-hydroxyproline in position 7.
    Buku A; Schwartz IL; Yamin N; Wyssbrod HR; Gazis D
    J Med Chem; 1987 Aug; 30(8):1509-12. PubMed ID: 3612693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of arginine vasopressin modified in position 2 or 3 with naphthylalanine: selective antagonists of oxytocin in-vitro.
    Sobocińska M; Lempicka E; Konieczna E; Derdowska I; Lammek B; Melhem S; Kozik W; Janecka J; Janecki M; Trzeciak HI
    J Pharm Pharmacol; 2000 Sep; 52(9):1105-12. PubMed ID: 11045891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
    Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
    Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
    J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
    Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
    J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some pharmacological actions of four synthetic analogues of oxytocin.
    BERDE B; DOEPFNER W; KONZETT H
    Br J Pharmacol Chemother; 1957 Jun; 12(2):209-14. PubMed ID: 13446374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.
    Derdowska I; Prahl A; Kowalczyk W; Janecki M; Melhem S; Trzeciak HI; Lammek B
    Eur J Med Chem; 2005 Jan; 40(1):63-8. PubMed ID: 15642410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antidiuretic and pressor activities of [arginine4]arginine-vasopressin and two related analogues.
    Rekowski P; Lammek B; Melin P; Ragnarsson U; Kupryszewski G
    Acta Chem Scand B; 1985; 39(6):453-7. PubMed ID: 4060959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.
    Kwiatkowska A; Lewandowska M; Borovičková L; Slaninová J; Lammek B; Prahl A
    Chem Biol Drug Des; 2013 Mar; 81(3):420-8. PubMed ID: 23205571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.